BIIB
BIIB
Biogen Inc.
$186.92
-$5.31 (-2.76%)
Mkt Cap: $27.60B
Home / BIIB / Financial Statements

Biogen Inc. (BIIB) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$9.86B
$9.81B ↑1.4%
$9.68B ↓1.6%
$9.84B ↓3.3%
$10.17B ↓7.4%
$10.98B
Cost of Revenue
$2.98B
$2.90B ↑25.4%
$2.31B ↓8.8%
$2.53B ↑11.2%
$2.28B ↑8.0%
$2.11B
Gross Profit
$6.88B
$6.91B ↓6.1%
$7.37B ↑0.9%
$7.30B ↓7.5%
$7.90B ↓11.0%
$8.87B
R&D Expenses
$1.98B
$1.95B ↓21.5%
$2.49B ↓7.9%
$2.70B ↑4.1%
$2.60B ↓23.6%
$3.40B
SG&A Expenses
$2.47B
$2.43B ↑2.0%
$2.39B ↓4.6%
$2.50B ↑3.9%
$2.41B ↓10.1%
$2.68B
Operating Income
$1.54B
$1.88B ↓24.6%
$2.49B ↑18.7%
$2.10B ↓27.4%
$2.89B ↑3.5%
$2.79B
Interest Expense
$275.10M
$246.00M ↓1.7%
$250.30M ↑1.4%
$246.90M ↑0.1%
$246.60M ↓2.8%
$253.60M
Income Tax
$95.61M
$108.11M ↓60.5%
$273.80M ↑102.4%
$135.30M ↓78.6%
$632.80M
$52.50M
Net Income
$1.37B
$1.29B ↓20.8%
$1.63B ↑40.6%
$1.16B ↓61.9%
$3.05B ↑95.8%
$1.56B
EBITDA
$2.79B
$3.10B ↑3.5%
$3.00B ↑26.0%
$2.38B ↓32.8%
$3.54B ↓9.9%
$3.92B
EPS
9.34
8.83 ↓21.1%
11.19 ↑40.4%
7.97 ↓61.8%
20.87 ↑100.7%
10.40
Shares Out (Diluted)
588.10M
146.70M ↑0.5%
145.90M ↑0.2%
145.60M ↓0.3%
146.00M ↓2.4%
149.60M